We found a loss of cytoplasmic positivity for IGF2 in 6 (30%) HCC, while the IHC expression was preserved (i.e. of the same intensity as in non-neoplastic liver) in the remaining cases (Figure 4). This evidence concerns the gene IGF2 and hepatocellular carcinoma.